MongoDB, Inc. (MDB) › Analysis

MongoDB, Inc. (MDB) analysis, March 17, 2026

Published March 17, 2026 · MDB chart, levels and live analysis

Key Updates

MongoDB rallied 4.52% to $272.45 on March 17, 2026, extending its post-earnings recovery to 10.4% from the March 13 low of $246.68. The stock has now reclaimed the critical $270 support level after three consecutive sessions of gains, though it remains 35% below its year-to-date starting point. The recovery continues despite no new fundamental catalysts, suggesting technical oversold conditions and bargain-hunting following the catastrophic 24% post-earnings decline. The stock has stabilized above $270 after testing this level multiple times since March 11, establishing a potential base for further recovery.

Current Trend

MongoDB remains in a severe downtrend on a YTD basis, down 35.08% through March 17, 2026, with the current price of $272.45 significantly below its year-opening levels. The stock experienced a catastrophic 24% single-day decline on March 3 following disappointing fiscal 2027 guidance, plummeting from approximately $320 to $246.68. Since establishing that low, the stock has mounted a 10.4% technical recovery, reclaiming the $270 support level that has served as a critical pivot point. The 6-month performance shows a 13.61% decline, while the 1-month chart reveals a brutal 26.05% drop concentrated around the earnings event. Recent price action shows improving momentum with gains of 2.06% (1-day) and 0.70% (5-day), suggesting stabilization after the earnings shock. Key resistance now sits at $280-$285, while support has established at $270, with the March 13 low of $246.68 representing the critical floor.

Investment Thesis

The investment thesis for MongoDB centers on its position as a leading database infrastructure provider in the AI application era, with Atlas cloud database revenue growing 29% year-over-year and the company achieving Rule of 40 performance. The company serves over 65,200 customers including approximately 75% of Fortune 100 companies, demonstrating enterprise-grade adoption. MongoDB's unified data platform provides operational data, search, real-time analytics, and AI-powered data retrieval capabilities essential for modern application development. The thesis is predicated on continued mid-to-high-teens revenue growth driven by AI applications, enterprise multi-cloud deployments, and integrated AI agent solutions. However, the thesis faces significant headwinds from decelerating growth rates, with fiscal 2027 revenue guidance indicating nearly 600 basis points of deceleration compared to fiscal 2026, intensifying competitive pressure in the database market, and execution risks following unexpected leadership changes in go-to-market operations. Morningstar maintains a $303 fair value estimate, suggesting 11% upside from current levels despite assigning no economic moat rating.

Thesis Status

The investment thesis has deteriorated materially but remains partially intact. While MongoDB continues to execute on product innovation and customer acquisition—adding 2,700 new customers in Q4 and achieving Atlas net revenue retention of 121% for three consecutive quarters—the sharp deceleration in growth guidance significantly undermines the growth narrative. The fiscal 2027 revenue growth guidance represents a deceleration of nearly 600 basis points compared to fiscal 2026, raising concerns about competitive dynamics and market saturation. The unexpected departure of the President of Field Operations and Chief Revenue Officer after a decade with the company introduces execution risk during a critical transition period. Management's admission of "limited visibility in the back half of the fiscal year" due to consumption-based pricing models adds uncertainty. However, the core thesis elements remain valid: MongoDB's technology remains differentiated for AI applications, vector search users doubled year-over-year, and the company maintains strong customer relationships with Fortune 100 enterprises. The 35% YTD decline has reset valuation expectations, with shares now trading below Morningstar's $303 fair value estimate, potentially creating an entry point for long-term investors willing to accept elevated execution risk.

Key Drivers

Negative Catalysts: Fiscal 2027 guidance disappointed significantly, with first-quarter adjusted earnings projected at $1.15-$1.19 per share versus $1.20 consensus and revenue guidance of $659-$664 million barely meeting expectations. Full-year fiscal 2027 revenue guidance of $2.86-$2.9 billion represents growth deceleration of nearly 600 basis points compared to fiscal 2026. Atlas cloud database growth decelerated to 29% in Q4 from 30% in Q3, with management providing no clear explanation for the slowdown. Leadership restructuring announced with the departure of President of Field Operations Cedric Pech and Chief Revenue Officer Paul Capombassis after a decade with the company. Following the results, 19 of 42 analysts lowered their price targets, reflecting diminished confidence in near-term execution.

Positive Catalysts: MongoDB achieved Rule of 40 performance, demonstrating the ability to drive revenue growth while expanding operating margins by 360 basis points year-over-year to 19%. Atlas net revenue retention expanded to 121% for three consecutive quarters, indicating strong customer expansion within the existing base. AI-related products showed momentum with vector search users doubling year-over-year, positioning MongoDB for potential AI-driven growth. The company added 2,700 new customers in Q4, bringing total customers to over 65,200, demonstrating continued market penetration. Morningstar maintains a $303 fair value estimate, suggesting meaningful upside from current levels following the post-earnings selloff.

Technical Analysis

MongoDB is attempting to establish a technical base after the March 3 earnings-driven collapse. The stock fell from approximately $320 to an intraday low of $246.68 on March 13, representing a 23% decline. Since then, the stock has recovered 10.4% to $272.45, successfully reclaiming the $270 level that has served as a critical support/resistance pivot. The current price action shows improving short-term momentum with three consecutive sessions of gains and positive 1-day (+2.06%) and 5-day (+0.70%) performance. However, the broader trend remains severely negative with YTD losses of 35.08%, 1-month losses of 26.05%, and 6-month losses of 13.61%. Key technical levels include immediate resistance at $280-$285 (the mid-March recovery highs), major resistance at $300-$303 (Morningstar fair value and psychological level), and critical support at $270 (current consolidation level) with the ultimate floor at $246.68 (March 13 low). The stock is trading well below all major moving averages, and volume patterns suggest the recent recovery is driven by technical oversold conditions rather than fundamental re-rating. A sustained break above $285 would signal a more meaningful recovery, while a failure to hold $270 could trigger another leg lower toward the $246 low.

Bull Case

Bear Case

Get a message when the MDB picture changes — the agent team watches the levels and the news for you.Create a free account

More MDB analyses